Pharma pours billions into direct-to-consumer (DTC) marketing, seeking to educate, empower, and improve patient outcomes. Yet in a 2024 survey, 73% of physicians reported that the medications their patients request aren’t always appropriate. In the same study, physicians also estimated that just 16% of their patients were well-informed about treatment options. So, is pharma’s investment in DTC really helping patients find the right therapy?
With skepticism from some HCPs, increasing privacy regulations, more specialized therapies, and rising ROI demands, DTC marketers’ job has never been harder. There’s no lack of data or media channels to choose from, and maybe that’s why the struggle to connect with the right patients is real. How do brands engage such a diverse pool of eligible patients?
But it’s not all doom and gloom, thanks to a combination of human ingenuity, a passion for better health, and yes, AI. There are pharma brands that have cracked the code on the evolving DTC landscape. Here’s what they have in common:
- Understanding Patients Holistically
No two patients are alike. Instead of just looking at broad, indication-level insights, brands can dive deeper into the details that really shape patient experiences—linking treatment patterns and key clinical moments with patient traits like lifestyle, cultural perspectives, and media habits. Through today’s data insights and technology, pharma marketers can reflect those differences with well-timed messaging and relevant creative, then place ads on consumers’ preferred channels. Not only does this create more meaningful connections and trust, it’s proven to deliver far better results for brands.
- Pinpointing the Right Timing
There’s only one moment a brand message is truly relevant — when it aligns to the need of a patient. When marketing is finely tuned to these key moments in the care journey, it’s easier to cut through the noise and stand out. Instead of outdated, broad-stroke audience segmentations, savvy brands are switching to AI-enabled, scalable approaches that predict their care milestones and target patients when they are ready to act.
- Overcoming the Privacy-Personalization Threat
Eighteen states have enacted their own privacy regulations, covering more than half the US population, and that number is only going to grow. Instead of skipping consumers in the states with more restrictive laws, brands are reaching those patients through hyperlocal, Zip9-based targeting approaches. This form of precision geotargeting introduces the right amount of strategic noise to stay compliant, while still allowing a personalized approach to message and channel mix.
So how have these brands created marketing programs that connect with the whole patient, line up with key care moments, and balance both personalization and privacy? They’ve adopted an adaptive, AI-enabled approach to audience segmentation. Let’s unpack this alliterative strategy—and why it’s proving to succeed.
What Are Adaptive Audiences?
Many DTC audiences are weakened by data that’s severely lagging by the time it reaches marketers. For example, real-world claims data can take up to three months to become available, which means it may not show a true picture of the patient landscape at the time a campaign begins. By prioritizing audience segments based on this potentially “stale” data, brand teams risk missing the mark when it comes to targeting the right consumers, selecting the right media, and getting the most value out of their spend.
Adaptive DTC audiences use a different methodology. They (re)prioritize audience segments throughout a campaign, based on current volumes of brand-eligible patients. That means they stay fresh in a way that conventional approaches can’t. Instead of “dated” data, adaptive audiences use artificial intelligence, predictive analytics, and human guidance to anticipate when patients are approaching brand eligibility and upcoming care visits. As a result, media is always optimized to reach the segments with the greatest opportunity for brand conversion. It’s a dynamic approach that reflects patients’ evolving care needs.
Dynamic Targeting, Remarkable Results
These flexible, adaptive audiences can drive up to six times higher script lift compared to conventional, fixed audience segmentations, with an average ROI of 28:1. One neurology brand, focused on an under-diagnosed condition, saw a 75% boost in the number of qualified patients reached and a 92% jump in patient engagement.
The case for change isn’t just about better marketing metrics—it’s about supporting and empowering patients as they move through their journey. By meeting patients where they are and anticipating what they’ll need next, adaptive audiences help brands thrive in the ever-evolving DTC space. The result? Better patient outcomes, stronger provider connections, and real commercial impact. And just maybe those HCP opinions about DTC marketing will change before we write the next article.